Matthew Richard Moore, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,610 shares at $16.52 ($25K) on 2023-03-02, disclosed to the SEC on 2023-03-06.
Scheduled sale ($25k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.82 | 1,589 | $25K | 98.6% |
| 2 | $16.52 | 21 | $347 | 1.4% |
| Total | $15.83 avg | 1,610 | $25K | 100% |
| Filing → |